Catalysts for The National Institute of Diabetes and Digestive and Kidney Diseases
3 tracked
Apr 30, 2026
phase 2 completion
The National Institute of Diabetes and Digestive and Kidney Diseases — undisclosed anti-diuretics (Phase II Trial Completion)
undisclosed anti-diuretics
→
Apr 27, 2026
phase 2 initiation
The National Institute of Diabetes and Digestive and Kidney Diseases — thioctic acid (Phase II Trial Initiation)
thioctic acid
→
Apr 27, 2026
phase 1 2 initiation
The National Institute of Diabetes and Digestive and Kidney Diseases — EBTATE (Phase I/II Trial Initiation)
EBTATE
→